LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.13 | 21.74 | 901 | 496 | 1.8152 | 1.2825 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.10 | 21.74 | 2 | 540 | 0.0037 | -0.4022 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.10 | 21.74 | 1033 | 540 | 1.9097 | 1.2994 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.10 | 21.74 | 1 | 540 | 0.0018 | -0.4852 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 14.10 | 21.74 | 927 | 540 | 1.7137 | 1.2464 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.07 | 21.74 | 1042 | 597 | 1.7429 | 1.2464 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 16.07 | 21.74 | 940 | 597 | 1.5723 | 1.1985 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.04 | 21.74 | 1 | 750 | 0.0013 | -0.4526 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.04 | 21.74 | 1066 | 750 | 1.4203 | 1.1421 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.04 | 21.74 | 1 | 750 | 0.0013 | -0.4526 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.04 | 21.74 | 988 | 750 | 1.3163 | 1.1105 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.01 | 21.74 | 3 | 901 | 0.0033 | -0.3082 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.01 | 21.74 | 1088 | 901 | 1.2063 | 1.0710 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.01 | 21.74 | 1 | 901 | 0.0011 | -0.4361 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.01 | 21.74 | 992 | 901 | 1.0999 | 1.0357 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.98 | 21.74 | 1 | 1108 | 0.0009 | -0.4189 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.98 | 21.74 | 1130 | 1108 | 1.0195 | 1.0068 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.98 | 21.74 | 1 | 1108 | 0.0009 | -0.4189 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 21.98 | 21.74 | 1012 | 1108 | 0.9131 | 0.9682 | MN20160310_N01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.95 | 21.74 | 1 | 1354 | 0.0007 | -0.4034 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.95 | 21.74 | 1144 | 1354 | 0.8446 | 0.9441 | MN20160310_N01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 23.95 | 21.74 | 1 | 1354 | 0.0007 | -0.4034 | MN20160310_N01 | L17 |